Printer-friendly versionPDF version

Frost & Sullivan hosts complimentary webinar discussing what all-time low grant funding rates mean for life science tools vendors

MOUNTAIN VIEW, Calif., United States., October 26, 2011 - (PressReleasePoint) - Contact:
Britni Myers
Frost & Sullivan                                                
+1.210.477.8481                                                           
britni.myers@frost.com

Update - Press Release

 
 
The Outlook for Academic Biomedical Research in the United States
 
Frost & Sullivan hosts complimentary webinar discussing what all-time low grant funding rates mean for life science tools vendors
 

MOUNTAIN VIEW, CA

WHEN:               Wednesday, Nov. 2, 2011 at 3 p.m. EDT
LOCATION:      Online, with free registration
SPEAKERS:     Jonathan Witonsky, Principal Analyst for Frost & Sullivan’s Life Sciences Research Tools practice
 
The academic customer base, which drives more than 20 percent of life science research tool sales, depends on federal grants for their funding. Potential cuts to federally funded U.S. research and development could have dire impacts on vendors of life science research tools. This analyst briefing will provide an outlook for academic biomedical research in the United States, investigating the potential impact that cuts in federal funding can have on life science tools vendors. The webinar will include analyses of the following market dynamics:

• Market size and growth for life science research tool sales to academic customers in the United States
• Academic customer survey data showing future purchasing plans
• Aggregate of vendors’ opinions regarding their sales to academic customers

 
This briefing will benefit manufacturers, distributors and service providers that serve academic life science researchers by discussing the general market outlook and providing demand-side and supply-side data for the United States life science research tools industry.
 
Supporting Quotes
“Vendors rely on academic customers for their continual robust growth, with annual sales to this segment traditionally growing at more than 5 percent,” said Principal Analyst Jonathan Witonsky. “Cutbacks in academic funding could mean tough times ahead for the industry, especially when coupled with an increasingly cost-conscience biopharmaceutical customer segment.”
 
 
Supporting Resources
For more information about Frost & Sullivan’s Healthcare practice, please visit: http://www.frost.com/healthcare
 
Registration

• To attend the briefing, email britni.myers@frost.com your full name, job title, company name, company telephone number, company email address and Web site, city, state and country.
• Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.

 
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
 
# # #